Valmark Advisers Inc. Acquires 234 Shares of Johnson & Johnson (NYSE:JNJ)
Valmark Advisers Inc. Acquires 234 Shares of Johnson & Johnson (NYSE:JNJ)
Valmark Advisers Inc. grew its holdings in Johnson & Johnson (NYSE:JNJ – Get Rating) by 1.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 23,109 shares of the company's stock after purchasing an additional 234 shares during the period. Valmark Advisers Inc.'s holdings in Johnson & Johnson were worth $3,775,000 at the end of the most recent quarter.
據Valmark Advisers Inc.在提交給美國證券交易委員會的最新披露中稱,該公司第三季度增持了強生(紐約證券交易所代碼:JNJ-GET評級)的股份1.0%。在此期間,該公司又購買了234股,持有該公司23,109股股票。截至最近一個季度末,Valmark Advisers Inc.持有的強生股份價值3,775,000美元。
Other hedge funds and other institutional investors also recently modified their holdings of the company. Morton Brown Family Wealth LLC increased its holdings in Johnson & Johnson by 78.0% during the 2nd quarter. Morton Brown Family Wealth LLC now owns 178 shares of the company's stock worth $32,000 after acquiring an additional 78 shares during the period. Goodman Advisory Group LLC purchased a new position in Johnson & Johnson in the 2nd quarter worth approximately $39,000. First Bank & Trust grew its stake in Johnson & Johnson by 69.6% in the 2nd quarter. First Bank & Trust now owns 380 shares of the company's stock worth $67,000 after buying an additional 156 shares in the last quarter. Heritage Wealth Management LLC purchased a new position in Johnson & Johnson in the 2nd quarter worth approximately $84,000. Finally, Timber Creek Capital Management LLC grew its stake in Johnson & Johnson by 225.0% in the 3rd quarter. Timber Creek Capital Management LLC now owns 650 shares of the company's stock worth $106,000 after buying an additional 450 shares in the last quarter. Institutional investors own 67.94% of the company's stock.
其他對衝基金和其他機構投資者最近也調整了對該公司的持股。第二季度,Morton Brown Family Wealth LLC增持強生股份78.0%。Morton Brown Family Wealth LLC在此期間額外收購了78股,現在擁有178股該公司股票,價值3.2萬美元。古德曼諮詢集團在第二季度購買了強生的一個新頭寸,價值約39,000美元。第一銀行信託第二季度增持強生股份69.6%。First Bank&Trust現在擁有380股該公司股票,價值6.7萬美元,在上個季度又購買了156股。遺產財富管理有限責任公司在第二季度購買了強生的一個新頭寸,價值約84,000美元。最後,Timber Creek資本管理有限責任公司在第三季度增持強生股份225.0%。Wood Creek Capital Management LLC現在擁有650股該公司股票,價值10.6萬美元,上個季度又購買了450股。機構投資者持有該公司67.94%的股份。
Wall Street Analysts Forecast Growth
華爾街分析師預測經濟增長
JNJ has been the subject of a number of research reports. Barclays initiated coverage on shares of Johnson & Johnson in a research note on Monday, October 17th. They issued an "equal weight" rating and a $175.00 price target for the company. StockNews.com started coverage on Johnson & Johnson in a research report on Wednesday, October 12th. They set a "strong-buy" rating on the stock. SVB Leerink decreased their target price on Johnson & Johnson from $194.00 to $186.00 and set an "outperform" rating on the stock in a research report on Friday, January 20th. Atlantic Securities boosted their target price on Johnson & Johnson from $160.00 to $168.00 and gave the stock a "neutral" rating in a research report on Wednesday. Finally, Morgan Stanley boosted their target price on Johnson & Johnson from $176.00 to $180.00 and gave the stock an "equal weight" rating in a research report on Wednesday. Seven research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $182.75.
JNJ已經成為許多研究報告的主題。巴克萊在10月17日星期一的一份研究報告中首次對強生的股票進行了報道。他們對該公司進行了“同等權重”評級,並設定了175.00美元的目標價。10月12日,星期三,斯托克新聞網開始在一份研究報告中對強生進行報道。他們對該股設定了“強力買入”評級。SVB Leerink在1月20日(週五)的一份研究報告中將強生的目標價從194.00美元下調至186.00美元,並對該股設定了“跑贏大盤”的評級。大西洋證券週三在一份研究報告中將強生的目標價從160.00美元上調至168.00美元,並給予該股中性評級。最後,摩根士丹利在週三的一份研究報告中將強生的目標價從176.00美元上調至180.00美元,並給予該股“同等權重”的評級。7名研究分析師對該股的評級為持有,5名分析師給出了買入評級,一名分析師對該公司股票發出了強烈的買入評級。根據MarketBeat.com的數據,該公司的共識評級為“適度買入”,共識目標價為182.75美元。
Insiders Place Their Bets
內部人士下注
Johnson & Johnson Stock Down 0.4 %
強生股價下跌0.4%
Shares of NYSE:JNJ opened at $168.89 on Friday. The company has a quick ratio of 1.18, a current ratio of 1.43 and a debt-to-equity ratio of 0.37. Johnson & Johnson has a 52-week low of $155.72 and a 52-week high of $186.69. The stock's fifty day simple moving average is $175.90 and its 200-day simple moving average is $171.04. The company has a market capitalization of $441.56 billion, a P/E ratio of 25.06, a P/E/G ratio of 3.00 and a beta of 0.56.
紐約證券交易所股票代碼:JNJ上週五開盤報168.89美元。該公司的速動比率為1.18,流動比率為1.43,債務權益比為0.37。強生目前的52周低點為155.72美元,52周高點為186.69美元。該股的50日簡單移動均線切入位為175.90美元,200日簡單移動均線切入位為171.04美元。該公司市值為4,415.6億美元,市盈率為25.06倍,市盈率為3.00倍,貝塔係數為0.56。
Johnson & Johnson (NYSE:JNJ – Get Rating) last announced its quarterly earnings results on Tuesday, January 24th. The company reported $2.35 EPS for the quarter, topping the consensus estimate of $2.22 by $0.13. The company had revenue of $23.71 billion during the quarter, compared to analyst estimates of $23.90 billion. Johnson & Johnson had a return on equity of 35.94% and a net margin of 18.90%. The firm's revenue was down 4.4% on a year-over-year basis. During the same period in the prior year, the firm posted $2.13 earnings per share. As a group, equities research analysts forecast that Johnson & Johnson will post 10.55 earnings per share for the current fiscal year.
強生(紐約證券交易所代碼:JNJ-GET Rating)最近一次公佈季度收益是在1月24日,星期二。該公司公佈本季度每股收益為2.35美元,比普遍預期的2.22美元高出0.13美元。該公司本季度營收為237.1億美元,而分析師預期為239億美元。強生的股本回報率為35.94%,淨利潤率為18.90%。該公司的收入同比下降了4.4%。去年同期,該公司公佈的每股收益為2.13美元。作為一個整體,股票研究分析師預測,強生本財年每股收益將達到10.55歐元。
Johnson & Johnson Announces Dividend
強生宣佈分紅
The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 7th. Shareholders of record on Tuesday, February 21st will be paid a dividend of $1.13 per share. The ex-dividend date of this dividend is Friday, February 17th. This represents a $4.52 annualized dividend and a yield of 2.68%. Johnson & Johnson's dividend payout ratio is presently 67.06%.
該公司最近還宣佈了季度股息,將於3月7日(星期二)支付。2月21日(星期二)登記在冊的股東將獲得每股1.13美元的股息。本次股息除息日期為2月17日(星期五)。這意味着年化股息為4.52美元,收益率為2.68%。強生目前的派息率為67.06%。
Johnson & Johnson Company Profile
強生公司簡介
(Get Rating)
(獲取評級)
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets.
強生是一家控股公司,從事醫療保健領域產品的研發、製造和銷售。它通過以下細分市場運作:消費者健康、製藥和醫療設備。消費者健康部分包括用於嬰兒護理、口腔護理、美容、非處方藥、婦女健康和傷口護理市場的產品。
Read More
閲讀更多內容
- Get a free copy of the StockNews.com research report on Johnson & Johnson (JNJ)
- EVs, Robotics Among Growth Drivers As Chipmaker STMicro Gaps Up
- Does Oil Services Firm NOV Have Enough Energy To Maintain Rally?
- Shopify Clears Cup-With-Handle Base: Can Momentum Continue?
- The Future Of E-Commerce: Analysis And New Data
- Chevron Delights Shareholders with $75 Billion in Share Buybacks
- 免費獲取斯托克新聞網關於強生(JNJ)的研究報告
- 電動汽車和機器人成為增長動力,芯片製造商意法半導體出現缺口
- 石油服務公司NOV有足夠的能量維持漲勢嗎?
- Shopify Clears杯柄基地:勢頭還能持續嗎?
- 電子商務的未來:分析和新數據
- 雪佛龍以750億美元的股票回購取悦股東
Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.
接受《強生日報》的新聞和評級-在下面輸入您的電子郵件地址,即可通過MarketBeat.com的免費每日電子郵件時事通訊接收對強生及相關公司的最新新聞和分析師評級的每日摘要。